Novartis South Africa

As a global medicines company, we see the true impact of serious diseases on patients, caregivers, and families every day. We understand the importance of listening to patient insights and learning from patient experiences to inform future decisions – from the development of new molecules to delivery of new treatment. By bridging the gap between science and humanity, we strive to ensure that every patient receives the care they deserve. #NovartisSA #ReimaginingMedicine #NovartisCares Fuse Approval FA-11268427 Approval date: 29 September 2024 Expiry Date: 29 September 2026

Arthritis - Not only an old-age disease. Juvenile idiopathic arthritis (JIA) is the most common type of arthritis affecting children under the age of 16 years, yet most cases of JIA in South Africa remain undiagnosed. Juvenile idiopathic arthritis is an autoimmune illness similar to adult rheumatoid arthritis in which the body targets healthy cells and tissues with an attack by the immune system. Genetics and environmental stressors are two possible causes of this illness, which means that it may run in families. Being knowledgeable about this condition will assist families in anticipating, preventing, and treating the effects of JIA later in life. To learn more about JIA, speak to a pediatric rheumatologist. #NovartisSA #ReimaginingMedicine #UndersatingJIA #WorldArthritisDay Fuse Approval FA-11268427 Approval date: 29 September 2024 Expiry Date: 29 September 2026

Did you know that the first or most obvious sign of breast cancer is not always a lump? Other signs of potential breast cancer include a change in the shape, size, color, or the feel of the breast or nipple. #NovartisSA #ReimaginingMedicine #BreastCancer #BreastCancerSigns Fuse Approval FA-11268427 Approval date: 29 September 2024 Expiry Date: 29 September 2026

When should you consider going for a breast cancer screening? * You’re a woman over 40 years old, or earlier if you have a family history of breast cancer. * You discover a lump in your breast or armpit or notice any other unusual changes around your breasts. Remember, early detection can significantly improve treatment outcomes. Keep an eye out for any changes in or around your breasts, and don't hesitate to talk to your healthcare professional if you have any questions or concerns. #NovartisSA #ReimaginingMedicine #CancerScreening #BreastCancer Fuse Approval FA-11268427 Approval date: 29 September 2024 Expiry Date: 29 September 2026

In South Africa, an estimated 19.4 million women aged 15 years and older are at risk of developing breast cancer. Moreover, breast cancer is a leading cause of death among South African women. At Novartis, we endeavor to transform breast cancer care by continuing to deliver treatment that extends and improve the lives of those with metastatic breast cancer and advance research into early breast cancer therapy options. #NovartisSA #ReimaginingMedicine #BreastCancer #Oncology #CancerResearch Fuse Approval FA-11268427 Approval date: 29 September 2024 Expiry Date: 29 September 2026

Are you beating to the rhythm? For most adults, a resting heart rate of between 60 and 100 beats per minute is considered normal. If your heart beats too quickly, too slowly, or inconsistently, it may be a sign of an arrythmia and could require medical attention. Consult a healthcare provider if you suspect you may have an irregular heartbeat. #NovartisSA #ReimaginingMedicine #HeartHealth Fuse Approval FA-11268427 Approval date: 29 September 2024 Expiry Date: 29 September 2026

Taking charge of your health begins with awareness. Routine annual screenings to monitor your blood pressure, cholesterol, and blood glucose levels could save your life. According to the Heart and Stroke Foundation South Africa, it is estimated that more than 50% of people with high blood pressure are unaware of their condition, which is a major risk factor for heart disease and strokes. Early detection means early action and better treatment outcomes, so why wait? Schedule your health screening today. #NovartisSA #ReimaginingMedicine #HeartHealth #HealthScreening

Did you know that hypertension and type 2 diabetes often coexist? Studies suggest that hypertension, or high blood pressure, is between two to three times more prevalent in people with diabetes compared to those without. If left untreated or improperly managed, these conditions can have serious health consequences. If you suffer from hypertension or diabetes, it is important to monitor your blood pressure and blood sugar levels regularly. If you are concerned, consult a healthcare professional for advice and guidance. #NovartisSA #ReimaginingMedicine #Diabetes #HeartHealth #Hypertension

Novartis is passionate about bringing quality healthcare to all patients in South Africa, allowing those in care to live their fullest lives possible. It is important to recognize the plight of those with limited mobility, which often hinders access to essential healthcare services. That is why Novartis South Africa has partnered with Unjani Clinics, a non-profit organization who seek to provide quality, primary healthcare services to under-served communities. Through this partnership, Novartis recently donated 100 wheelchairs to support patients with mobility challenges. Through such initiatives, we aim to make healthcare more inclusive for all. #NovartisSA #ReimaginingMedicine #HealthcareAccess FA-11234430, FA-11234428

Women's Month is a particularly important opportunity for celebration at Novartis. This year's theme, '𝙄𝙣𝙫𝙚𝙨𝙩 𝙞𝙣 𝙬𝙤𝙢𝙚𝙣: 𝙖𝙘𝙘𝙚𝙡𝙚𝙧𝙖𝙩𝙚 𝙥𝙧𝙤𝙜𝙧𝙚𝙨𝙨' is a perfect fit for what we do here every day. Our 'Unbossed' culture ensures that we always keep the wellbeing of our associates in mind, as we invest in people and help them expand their horizons. Through this, we continually drive equality while challenging outdated gender norms in everything we do. To celebrate the tenacity and the many achievements of our female colleagues, and the impact of women in our industry as a whole, we recently hosted a Women's Day high tea event, hearing from our Interim Country President, Riëtte Viljoen, and Head of Public Affairs, Derrick Ellan on what gender equality means to us all. The women of Novartis will continue to push boundaries in medicine, and together we'll ensure that every person who comes our way is empowered and shares in our successes #NovartisSA #ReimaginingMedicine #NovartisCulture #Women’sDay2024 #Women’sMonth FUSE approval: Approval Date: 8/14/2024/ Exp Date: 8/16/2026 /Content ID: FA-11249577